2:57 PM
 | 
Jul 10, 2018
 |  BC Extra  |  Company News

Management tracks: G1, Collegium, Nimbus

Cancer company G1 Therapeutics Inc. (NASDAQ:GTHX) hired John Demaree as chief commercial officer and Stillman Hanson as general counsel. Demaree was VP of oncology marketing at Astellas Pharma Inc. (Tokyo:4503). Hanson was associate general counsel and VP at Quintiles Transnational Holdings Inc., which is now part of IQVia Holdings Inc. (NYSE:IQV).

Pain company Collegium Pharmaceutical Inc. (NASDAQ:COLL) promoted Scott Dreyer to EVP and COO from SVP of sales, marketing and training.

Computational biology company Nimbus Therapeutics LLC (Cambridge, Mass.) hired Adrian Ray as SVP of discovery biology. He was senior director of clinical research at Gilead Sciences Inc. (NASDAQ:GILD).

Antibody company Syntimmune Inc. (Boston, Mass.) hired Mario Saltarelli as CMO. He was SVP at Vertex Pharmaceuticals Inc. (NASDAQ:VRTX).

T cell immunotherapy company Tmunity Therapeutics Inc. (Philadelphia, Pa.) hired Christina Coughlin as CMO and EVP. She was CMO at Immunocore Ltd. (Abingdon, U.K.).

Orphan disease company Dynacure S.A.S. (Illkirch, France) hired Chris Freitag as CMO. He was head of clinical R&D at the Debiopharm International S.A. unit of Debiopharm Group (Lausanne, Switzerland).

Biologics company Immusoft Corp. (Seattle, Wash.) hired Jason Fontenot as CSO. He was head of exploratory research at Juno Therapeutics Inc., which Celgene Corp. (NASDAQ:CELG) acquired.

AI company Recursion Pharmaceuticals Inc. (Salt Lake City, Utah) named Tina Larson as COO. She was SVP of technical operations at Achaogen Inc. (NASDAQ:AKAO).

Infectious disease diagnostic company PathoQuest S.A.S. (Paris, France) hired Stéphane Cruveiller as chief technology information officer. He was team leader at the French Alternative Energies and Atomic Energy Commission.

Cell therapy company Nkarta Inc. (South San Francisco, Calif.) hired Nadir Mahmood as SVP of corporate development. Mahmood was senior director of corporate development at Second Genome Inc. (South San Francisco, Calif.).

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

Purchase this article for limited one-time distribution and website posting

$750 USD